• Something wrong with this record ?

Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins

S. Mamrut, N. Avidan, F. Truffault, E. Staun-Ram, T. Sharshar, B. Eymard, M. Frenkian, J. Pitha, M. de Baets, L. Servais, S. Berrih-Aknin, A. Miller,

. 2017 ; 82 (-) : 62-73. [pub] 20170524

Language English Country England, Great Britain

Document type Journal Article, Twin Study

OBJECTIVE: To identify novel genetic and epigenetic factors associated with Myasthenia gravis (MG) using an identical twins experimental study design. METHODS: The transcriptome and methylome of peripheral monocytes were compared between monozygotic (MZ) twins discordant and concordant for MG, as well as with MG singletons and healthy controls, all females. Sets of differentially expressed genes and differentially methylated CpGs were validated using RT-PCR for expression and target bisulfite sequencing for methylation on additional samples. RESULTS: >100 differentially expressed genes and ∼1800 differentially methylated CpGs were detected in peripheral monocytes between MG patients and controls. Several transcripts associated with immune homeostasis and inflammation resolution were reduced in MG patients. Only a relatively few genes differed between the discordant healthy and MG co-twins, and both their expression and methylation profiles demonstrated very high similarity. INTERPRETATION: This is the first study to characterize the DNA methylation profile in MG, and the expression profile of immune cells in MZ twins with MG. Results suggest that numerous small changes in gene expression or methylation might together contribute to disease. Impaired monocyte function in MG and decreased expression of genes associated with inflammation resolution could contribute to the chronicity of the disease. Findings may serve as potential new predictive biomarkers for disease and disease activity, as well as potential future targets for therapy development. The high similarity between the healthy and the MG discordant twins, suggests that a molecular signature might precede a clinical phenotype, and that genetic predisposition may have a stronger contribution to disease than previously assumed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024988
003      
CZ-PrNML
005      
20180716121756.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jaut.2017.05.005 $2 doi
035    __
$a (PubMed)28549776
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mamrut, Shimrat $u Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 31096, Israel.
245    10
$a Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins / $c S. Mamrut, N. Avidan, F. Truffault, E. Staun-Ram, T. Sharshar, B. Eymard, M. Frenkian, J. Pitha, M. de Baets, L. Servais, S. Berrih-Aknin, A. Miller,
520    9_
$a OBJECTIVE: To identify novel genetic and epigenetic factors associated with Myasthenia gravis (MG) using an identical twins experimental study design. METHODS: The transcriptome and methylome of peripheral monocytes were compared between monozygotic (MZ) twins discordant and concordant for MG, as well as with MG singletons and healthy controls, all females. Sets of differentially expressed genes and differentially methylated CpGs were validated using RT-PCR for expression and target bisulfite sequencing for methylation on additional samples. RESULTS: >100 differentially expressed genes and ∼1800 differentially methylated CpGs were detected in peripheral monocytes between MG patients and controls. Several transcripts associated with immune homeostasis and inflammation resolution were reduced in MG patients. Only a relatively few genes differed between the discordant healthy and MG co-twins, and both their expression and methylation profiles demonstrated very high similarity. INTERPRETATION: This is the first study to characterize the DNA methylation profile in MG, and the expression profile of immune cells in MZ twins with MG. Results suggest that numerous small changes in gene expression or methylation might together contribute to disease. Impaired monocyte function in MG and decreased expression of genes associated with inflammation resolution could contribute to the chronicity of the disease. Findings may serve as potential new predictive biomarkers for disease and disease activity, as well as potential future targets for therapy development. The high similarity between the healthy and the MG discordant twins, suggests that a molecular signature might precede a clinical phenotype, and that genetic predisposition may have a stronger contribution to disease than previously assumed.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a CpG ostrůvky $7 D018899
650    12
$a metylace DNA $7 D019175
650    _2
$a epigeneze genetická $7 D044127
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a monocyty $x imunologie $x metabolismus $7 D009000
650    _2
$a myasthenia gravis $x genetika $x metabolismus $7 D009157
650    _2
$a signální transdukce $7 D015398
650    12
$a transkriptom $7 D059467
650    _2
$a receptor TREM-1 $x genetika $x metabolismus $7 D000073871
650    12
$a dvojčata monozygotní $7 D014430
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a studie na dvojčatech $7 D018486
700    1_
$a Avidan, Nili $u Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 31096, Israel.
700    1_
$a Truffault, Frédérique $u INSERM - U974/CNRS UMR7215//UPMC UM76/AIM, Institute of Myology Pitie-Salpetriere, Paris, 73013, France.
700    1_
$a Staun-Ram, Elsebeth $u Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 31096, Israel.
700    1_
$a Sharshar, Tarek $u General Intensive Care Medicine, Assistance Publique Hôpitaux de Paris, Raymond Poincaré Hospital, University of Versailles Saint-Quentin en Yvelines, 92380, Garches, France.
700    1_
$a Eymard, Bruno $u Department of Neuromuscular Disorders, CHU Salpêtrière, Paris, 75013, France.
700    1_
$a Frenkian, Mélinée $u INSERM - U974/CNRS UMR7215//UPMC UM76/AIM, Institute of Myology Pitie-Salpetriere, Paris, 73013, France.
700    1_
$a Pitha, Jiri $u Department of Neurology and Clinical Neuroscience Center, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague, Czech Republic.
700    1_
$a de Baets, Marc $u Neuroimmunology Group, Division of Neuroscience, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
700    1_
$a Servais, Laurent $u Institute of Myology, Groupe hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités, UPMC Universités Paris 06, INSERM, Paris, 75013, France.
700    1_
$a Berrih-Aknin, Sonia $u INSERM - U974/CNRS UMR7215//UPMC UM76/AIM, Institute of Myology Pitie-Salpetriere, Paris, 73013, France.
700    1_
$a Miller, Ariel $u Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, 31096, Israel; Division of Neuroimmunology, Lady Davis Carmel Medical Center, Haifa, 34362, Israel. Electronic address: milleras@netvision.net.il.
773    0_
$w MED00002536 $t Journal of autoimmunity $x 1095-9157 $g Roč. 82, č. - (2017), s. 62-73
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28549776 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180716122054 $b ABA008
999    __
$a ok $b bmc $g 1317119 $s 1021909
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 82 $c - $d 62-73 $e 20170524 $i 1095-9157 $m Journal of autoimmunity $n J Autoimmun $x MED00002536
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...